News and Trends 3 Mar 2020 Alnylam Gets Second RNAi Drug Approval from EMA US biotech Alnylam Pharmaceuticals has succeeded in getting its second RNAi drug — for treatment of rare, inherited liver diseases — approved by the European Medicines Authority just months after achieving US FDA approval for the same drug. Alnylam are well known for being pioneers in the RNA interference space. The company achieved the first […] March 3, 2020 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 2 Mar 2020 Evonetix Raises €27M Series B to Progress DNA Synthesis Technology UK synthetic biology company Evonetix raised €27M in Series B funding to develop its fast DNA synthesis technology and produce a working prototype of the company’s desktop platform. New investor Foresite Capital, a US-based VC firm, led the round, although all the company’s earlier Series A investors, such as the tech-focused VC’s Draper Esprit and […] March 2, 2020 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 26 Feb 2020 Bicycle Therapeutics Partners Genentech in Deal Worth €1.6B UK biotech Bicycle Therapeutics will collaborate with Genentech, now part of the Roche Group, to develop novel cancer immunotherapies and take them to market. Genentech will pay €28M upfront to Bicycle, but if discovery, regulatory and commercial milestones are met then the deal could be worth up to €1.6B for the Cambridge-based company. Bicycle’s technology […] February 26, 2020 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 24 Feb 2020 Adrenomed’s Antibody Drug Scores Hit in Phase II Septic Shock Trial German biotech Adrenomed reports that its first-in-class antibody drug adrecizumab was well-tolerated by septic shock patients and met its primary goal in a phase II trial. The company says it will release more detailed trial data in a peer-reviewed paper later in the year, but states that patients given adrecizumab, as opposed to placebo, had […] February 24, 2020 - 3 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 18 Feb 2020 OncoDNA Secures €19M to Progress Precision Cancer Treatment Technology Belgian biotech OncoDNA has raised €19M in Series B funding to further develop its cancer diagnostic and therapeutic decision-making software. The funding was led by Vesalius Biocapital, a Luxembourg-based VC investor, Swiss VC firm Swisscanto Invest by Zürcher Kantonalbank, and Belgian VC company SFPI-FPIM. Early investors in the company such as CPH Bank also contributed […] February 18, 2020 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
In Depth 11 Feb 2020 Why European Biotechs Should Look to China for Investment Traditionally European biotechs have looked to the US for additional investment, but changes in the law and significant economic success in the country in recent years means that new opportunities are opening up in China that are ripe for exploitation. China has a massive population and a correspondingly large patient group. Homegrown science is pretty […] February 11, 2020 - 8 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
Expert Advice 6 Feb 2020 Why a Big Pharma Background Can Give Biotech Leaders an Edge Many biotech founders come straight from academia and may struggle with the new skill set that is required to run a company. Rob de Ree, CEO of Dutch biotech NorthSea Therapeutics, has a background in big pharma and medtech and believes his earlier experience was instrumental to his success as a biotech leader. After spending […] February 6, 2020 - 11 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 Jan 2020 10 Scientists Behind Modern Biotech You Probably Don’t Know The modern biotech industry is a multi-million euro business, but who are the Europeans behind the science that made the industry what it is today? Here are 10 scientists, engineers and healthcare professionals we think you should know about. Over the last 25 years, biotech has become a burgeoning worldwide industry. It only became the […] January 28, 2020 - 8 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 16 Jan 2020 BioNTech Expands Cancer Portfolio With US Biotech Acquisition German cancer specialist BioNTech will acquire US T-cell therapy biotech Neon Therapeutics in a deal worth €60M, both to expand its cancer therapy pipeline and establish a US base. The deal is expected to complete in the second half of 2020, after which Neon will operate as a subsidiary of BioNTech. BioNTech has arguably scooped […] January 16, 2020 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
Expert Advice 15 Jan 2020 How to Spot a Biotech Winner: Investment Lessons from Sofinnova Making one biotech a success is hard enough, but correctly predicting multiple winners is the bread and butter of Antoine Papiernik, Managing Partner of Sofinnova Partners, one of the biggest and most prosperous life science venture capital investors in Europe. Papiernik began his career in corporate finance. In 1995, he was working in investment in […] January 15, 2020 - 10 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 8 Jan 2020 Therachon Founders Spin Out New Rare Disease Biotech With €31M Investment The founders of Swiss biotech Therachon have launched a new company called VectivBio, also based in Basel, with €31M funding to develop drugs for rare diseases. The spin-out comes after Therachon was acquired by Pfizer last year in a deal worth up to €700M. Therachon’s CEO, CBO, CFO and CMO will all move to the […] January 8, 2020 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
Interview 18 Dec 2019 How BioNTech Navigates the Biotech Fundraising Maze BioNTech is on a mission to individualize cancer therapy by developing a range of different innovative therapies, a task that can be a rollercoaster ride, according to its Chief Business and Commercial Officer Sean Marett. It’s been an interesting year for the German biotech. In July the company raised one of the biggest ever European […] December 18, 2019 - 6 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email